184 related articles for article (PubMed ID: 32975433)
1. Intact mAb LC-MS for drug concentration from pre-clinical studies: bioanalytical method performance and in-life samples.
Kellie JF; Alelyunas YW; Albert J; Schneck NA; Chen Z; Sychterz CJ; Edwards I; Shion H; Wrona MD; Szapacs ME
Bioanalysis; 2020 Oct; 12(19):1389-1403. PubMed ID: 32975433
[No Abstract] [Full Text] [Related]
2. Comparison of bioanalytical methods for the quantitation of PEGylated human insulin.
de Dios K; Manibusan A; Marsden R; Pinkstaff J
J Immunol Methods; 2013 Oct; 396(1-2):1-7. PubMed ID: 23933323
[TBL] [Abstract][Full Text] [Related]
3. Recommendations for validation of LC-MS/MS bioanalytical methods for protein biotherapeutics.
Jenkins R; Duggan JX; Aubry AF; Zeng J; Lee JW; Cojocaru L; Dufield D; Garofolo F; Kaur S; Schultz GA; Xu K; Yang Z; Yu J; Zhang YJ; Vazvaei F
AAPS J; 2015 Jan; 17(1):1-16. PubMed ID: 25392238
[TBL] [Abstract][Full Text] [Related]
4. Two validated liquid chromatography-mass spectrometry methods with different pretreatments for the quantification of an anti-CD47 monoclonal antibody in rat and cynomolgus monkey serum compared with an electrochemiluminescence method.
Gao Y; Zhang D; Yang C; Duan X; Li X; Zhong D
J Pharm Biomed Anal; 2019 Oct; 175():112792. PubMed ID: 31377653
[TBL] [Abstract][Full Text] [Related]
5. Attribution of the discrepancy between ELISA and LC-MS/MS assay results of a PEGylated scaffold protein in post-dose monkey plasma samples due to the presence of anti-drug antibodies.
Wang SJ; Wu ST; Gokemeijer J; Fura A; Krishna M; Morin P; Chen G; Price K; Wang-Iverson D; Olah T; Weiner R; Tymiak A; Jemal M
Anal Bioanal Chem; 2012 Jan; 402(3):1229-39. PubMed ID: 22130720
[TBL] [Abstract][Full Text] [Related]
6. Comparison of methods for quantitative analysis of ranibizumab and bevacizumab in human plasma using various bioanalytical techniques, including microfluidic immunoassay, triple quadrupole, and high-resolution liquid chromatography-tandem mass spectrometry approaches.
DelGuidice CE; Ismaiel OA; Mylott WR; Halquist MS
J Pharm Biomed Anal; 2022 Aug; 217():114823. PubMed ID: 35576733
[TBL] [Abstract][Full Text] [Related]
7. Optimization and method validation for the quantitative analysis of a monoclonal antibody and its related fab fragment in human plasma after intravitreal administration, using LC-MS/MS.
DelGuidice CE; Ismaiel OA; Mylott WR; Halquist MS
J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Feb; 1164():122474. PubMed ID: 33508760
[TBL] [Abstract][Full Text] [Related]
8. Critical role of bioanalytical strategies in investigation of clinical PK observations, a Phase I case study.
Peng K; Xu K; Liu L; Hendricks R; Delarosa R; Erickson R; Budha N; Leabman M; Song A; Kaur S; Fischer SK
MAbs; 2014; 6(6):1500-8. PubMed ID: 25484037
[TBL] [Abstract][Full Text] [Related]
9. A versatile method for protein-based antigen bioanalysis in non-clinical pharmacokinetics studies of a human monoclonal antibody drug by an immunoaffinity liquid chromatography-tandem mass spectrometry.
Onami I; Ayabe M; Murao N; Ishigai M
J Chromatogr A; 2014 Mar; 1334():64-71. PubMed ID: 24572547
[TBL] [Abstract][Full Text] [Related]
10. Perspectives on potentiating immunocapture-LC-MS for the bioanalysis of biotherapeutics and biomarkers.
Sugimoto H; Wei D; Dong L; Ghosh D; Chen S; Qian MG
Bioanalysis; 2018 Oct; 10(20):1679-1690. PubMed ID: 30371100
[TBL] [Abstract][Full Text] [Related]
11. Use of generic LC-MS/MS assays to characterize atypical PK profile of a biotherapeutic monoclonal antibody.
Law WS; Genin JC; Miess C; Treton G; Warren AP; Lloyd P; Dudal S; Krantz C
Bioanalysis; 2014; 6(23):3225-35. PubMed ID: 25529889
[TBL] [Abstract][Full Text] [Related]
12. Protein LC-MS Tools for the Next Generation of Biotherapeutic Analyses from Preclinical and Clinical Serum.
Schneck NA; Mehl JT; Kellie JF
J Am Soc Mass Spectrom; 2023 Sep; 34(9):1837-1846. PubMed ID: 37478497
[TBL] [Abstract][Full Text] [Related]
13. Integration of protein L-immobilized epoxy magnetic bead capture with LC-MS/MS for therapeutic monoclonal antibody quantification in serum.
Cao R; Xu S; Yu Z; Xu L; Ge Z; Huo Q; Zhu G; Qiao B
Anal Methods; 2024 Jun; 16(23):3720-3731. PubMed ID: 38808588
[TBL] [Abstract][Full Text] [Related]
14. LC-MS-based quantification of intact proteins: perspective for clinical and bioanalytical applications.
van den Broek I; van Dongen WD
Bioanalysis; 2015; 7(15):1943-58. PubMed ID: 26295992
[TBL] [Abstract][Full Text] [Related]
15. Bioanalytical method development and validation: Critical concepts and strategies.
Moein MM; El Beqqali A; Abdel-Rehim M
J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Feb; 1043():3-11. PubMed ID: 27720355
[TBL] [Abstract][Full Text] [Related]
16. Development and multicenter validation of an LC-MS-based bioanalytical method for antisense therapeutics.
Sun Y; Nitta SI; Saito K; Hosogai R; Nakai K; Goda R; Shimizu H; Fujita H; Kakehi M; Murata K; Yamaguchi T; Okuzono T; Yamane S; Kawabata M; Matsunuma T; Takahara K; Kato N; Yamada M; Yoshida T; Inoue T; Saito Y
Bioanalysis; 2022 Sep; 14(18):1213-1227. PubMed ID: 36408704
[No Abstract] [Full Text] [Related]
17. Biotherapeutic Antibody Subunit LC-MS and Peptide Mapping LC-MS Measurements to Study Possible Biotransformation and Critical Quality Attributes In Vivo.
Kellie JF; Thomson AS; Chen S; Childs SL; Karlinsey MZ; Mai SH; White JR; Biddlecombe RA
J Pharm Sci; 2019 Apr; 108(4):1415-1422. PubMed ID: 30465782
[TBL] [Abstract][Full Text] [Related]
18. A strategy for liquid chromatography/tandem mass spectrometry based quantitation of pegylated protein drugs in plasma using plasma protein precipitation with water-miscible organic solvents and subsequent trypsin digestion to generate surrogate peptides for detection.
Wu ST; Ouyang Z; Olah TV; Jemal M
Rapid Commun Mass Spectrom; 2011 Jan; 25(2):281-90. PubMed ID: 21192023
[TBL] [Abstract][Full Text] [Related]
19. Eliminating Preparation of Multisample External Calibration Curves and Dilution of Study Samples Using the Multiple Isotopologue Reaction Monitoring (MIRM) Technique in Quantitative LC-MS/MS Bioanalysis.
Gu H; Zhao Y; DeMichele M; Zheng N; Zhang YJ; Pillutla R; Zeng J
Anal Chem; 2019 Jul; 91(13):8652-8659. PubMed ID: 31180205
[TBL] [Abstract][Full Text] [Related]
20. LC-MS/MS determination of a human mAb drug candidate in rat serum using an isotopically labeled universal mAb internal standard.
Li W; Lin H; Fu Y; Flarakos J
J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Feb; 1044-1045():166-176. PubMed ID: 28113139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
